...
首页> 外文期刊>International journal of antimicrobial agents >In vitro activities of beta-lactam antibiotics alone and in combination with sulbactam against Gram-negative bacteria
【24h】

In vitro activities of beta-lactam antibiotics alone and in combination with sulbactam against Gram-negative bacteria

机译:β-内酰胺类抗生素单独使用或与舒巴坦合用对革兰氏阴性菌的体外活性

获取原文
获取原文并翻译 | 示例
           

摘要

The resistance rates of ampicillin/sulbactam 2:1 against imipenem-susceptible and -resistant Acinetobacter baumannii were 23.5 and 30%, respectively. Ceftazidime/sulbactam combination showed significant reduction of resistant rates against Enterobacter cloacae, A. baumannii, ESBL Klebsiella pneumoniae. MIC90 of cefoperazone against E. cloacae, Serratia marcescens, A. baumannii and ESBL K. pneumoniae were > 128 mg/l. Addition of sulbactam enhanced the antimicrobial activities significantly. When imipenem was combined with sulbactam, the resistant rates against imipenem-resistant A. baumanni were significantly reduced. Cefepime/sulbactam combination was active against imipenem-resistant A. baumanni. The resistance rates of aztreonam/sulbactam combination against E. cloacae, imipenem-sensitive and resistant A. baumannii, ESBL K. pneumoniae were lowered significantly. The cefotaxime/sulbactam combination showed a significant improvement of activities against E. cloacae, S. marcescens, A. baumannii and ESBL K. pneumoniae. (C) 2004 Elsevier B.V. and the International Society of Chemotherapy. All rights reserved.
机译:氨苄西林/舒巴坦2:1对亚胺培南敏感和耐药鲍曼不动杆菌的耐药率分别为23.5和30%。头孢他啶/舒巴坦组合显示出对阴沟肠杆菌,鲍曼不动杆菌,ESBL肺炎克雷伯菌的耐药率显着降低。头孢哌酮对阴沟肠杆菌,粘质沙雷氏菌,鲍曼不动杆菌和ESBL肺炎克雷伯菌的MIC90均大于128 mg / l。舒巴坦的添加显着增强了抗菌活性。当亚胺培南与舒巴坦合用时,对亚胺培南耐药鲍曼不动杆菌的耐药率显着降低。头孢吡肟/舒巴坦联合用药对亚胺培南耐药的鲍曼不动杆菌具有活性。氨曲南/舒巴坦组合对阴沟肠杆菌,亚胺培南敏感和耐药鲍曼不动杆菌,ESBL肺炎克雷伯菌的耐药率显着降低。头孢噻肟/舒巴坦组合显示出对阴沟肠杆菌,marcescens,鲍曼不动杆菌和ESBL肺炎克雷伯菌的活性有显着改善。 (C)2004年Elsevier B.V.和国际化学疗法学会。版权所有。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号